REQUEST A DEMO
Total
USD $0.00
Search more companies

Sanford Biotech Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Medical Equipment and Supplies Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | Research and Development in Biotechnology (except Nanobiotechnology) | Veterinary Services | Medical and Diagnostic Laboratories | All Other Miscellaneous Ambulatory Health Care Services
Full name: Sanford Biotech Sp. z o.o. Profile Updated: March 11, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Sanford Biotech Sp. z o.o. is based in Poland, with the head office in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on July 20, 2017. There was a net sales revenue increase of 13.5% reported in Sanford Biotech Sp. z o.o.’s latest financial highlights for 2024. There was a total growth of 994.36% in Sanford Biotech Sp. z o.o.’s total assets over the same period. In, 2024, the company’s net profit margin decreased by 294.05%.

Headquarters
Ul. Aleja Marsz. Jozefa Pilsudskiego 35/E
Warsaw; Mazowieckie; Postal Code: 05-077

Contact Details: Purchase the Sanford Biotech Sp. z o.o. report to view the information.

Website: http://www.sanfordbiotech.com

Basic Information
Registered Capital:
Purchase the Sanford Biotech Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Sanford Biotech Sp. z o.o. report to view the information.
Incorporation Date:
July 20, 2017
Key Executives
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
63.64%
Company Performance
Financial values in the chart are available after Sanford Biotech Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
13.5%
Total Operating Revenue
-7.05%
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
-237.09%
Total Assets
994.36%
Total Equity
-71.38%
Operating Profit Margin
N/A
Net Profit Margin
-294.05%
Return on Equity (ROE)
20.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?